Lentiviral vectors mediate nonimmunosuppressive rapamycin analog-induced production of secreted therapeutic factors in the brain: Regulation at the level of transcription and exocytosis

Human Gene Therapy

Volumn 19, Issue 2, 2008, Pages 167-178

  Vogel, Roland ^a   Mammeri, Hamid ^a   Mallet, Jacques ^a,b  

^a CNRS   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GREEN FLUORESCENT PROTEIN; IMMUNOSUPPRESSIVE AGENT; LENTIVIRUS VECTOR; POLYPEPTIDE; RAPAMYCIN;

ARTICLE; CONTROLLED STUDY; EXOCYTOSIS; FEMALE; GENE EXPRESSION; GENE SEQUENCE; GENE THERAPY; GENE TRANSFER; HISTOPATHOLOGY; IN VITRO STUDY; MOUSE; NONHUMAN;

ANIMALS; BRAIN; CELL LINE; EXOCYTOSIS; FEMALE; GENETIC VECTORS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LENTIVIRUS; MICE; PEPTIDES; SIROLIMUS; TRANSCRIPTION, GENETIC; TRANSDUCTION, GENETIC;

MUS;

EID: 39449107752     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2007.125     Document Type: Article

References (39)

1. AURICCHIO, A., RIVERA, V.M., CLACKSON, T., O'CONNOR, E.E., MAGUIRE, A.M., TOLENTINO, M.J., BENNETT, J., and WILSON, J.M. (2002). Pharmacological regulation of protein expression from adeno-associated viral vectors in the eye. Mol. Ther. 6, 238-242.
2. BARDE, I., ZANTA-BOUSSIF, M.A., PAISANT, S., LEBOEUF, M., RAMEAU, P., DELENDA, C., and DANOS, O. (2006). Efficient control of gene expression in the hematopoietic system using a single Tet-on inducible lentiviral vector. Mol. Ther. 13, 382-390.
3. BENSADOUN, J.-C., DÉGLON, N., TSENG, J.L., RIDET, J.-L., ZURN, A.D., and AEBISCHER, P. (2000). Lentiviral vectors as gene delivery systems in the mouse midbrain: Cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF. Exp. Neurol. 164, 15-24.
4. BILANG-BLEUEL, A., REVAH, F., COLIN, P., LOCQUET, I., ROBERT, J.J., MALLET, J., and HORELLOU, P. (1997). Intrastriatal injection of an adenoviral vector expressing glial cell line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 94, 8818-8823.
5. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
6. BURNETTE, W.N. (1981). "Western blotting": Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem. 112, 195-203.
7. CHTARTO, A., BENDER, H.U., HANEMANN, C.O., KEMP, T., LEHTONEN, E., LEVIVIER, M., BROTCHI, J., VELU, T., and TENENBAUM, L. (2003). Tetracycline-inducible transgene expression mediated by a single AAV vector. Gene Ther. 10, 84-94.
8. CORTI, O., SANCHEZ-CAPELO, A., COLIN, P., HANOUN, N., HAMON, M., and MALLET, J. (1999). Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 96, 12120-12125.
9. DAVIS, A.A., BERNSTEIN, P.S., BOK, D., TURNER, J., NACHTIGAL, M., and HUNT, R.C. (1995). A human retinal pigment epithelial cell line that retains epithelial characteristics after prolonged culture. Invest. Ophthalmol. Vis. Sci. 36, 955-964.
10. DHILLON, H., KALRA, S.P., and KALRA, P.S. (2001). Dose-dependent effects of central leptin gene therapy on genes that regulate body weight and appetite in the hypothalamus. Mol. Ther. 4, 139-145.
11. FANG, J., QIAN, J.J., YI, S., HARDING, T.C., TU, G.H., VANROEY, M., and JOOSS, K. (2005). Stable antibody expression at therapeutic levels using the 2A peptide. Nat. Biotechnol. 23, 584-590.
12. FRASSON, M., PICAUD, S., LEVEILLARD, T., SIMONUTTI, M., MOHAND-SAID, S., DREYFUS, H., HICKS, D., and SABEL, J. (1999). Glial cell line-derived neutrophic factor induces histologic and functional protection of rod photoreceptors in the rd/rd mouse. Invest. Ophthalmol. Vis. Sci. 40, 2724-2743.
13. FUSSENEGGER, M. (2001). The impact of mammalian gene regulation concepts on functional genomic research, metabolic engineering, and advanced gene therapies. Biotechnol Prog. 17, 1-51.
14. GEORGIEVSKA, B., KIRIK, D., and BJÖRKLUND, A. (2002). Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line-derived neurotrophic factor in the striatum by lentiviral gene transfer. Exp. Neurol. 177, 461-474.
15. GEORGIEVSKA, B., KIRIK, D., and BJÖRKLUND, A. (2004). Overexpression of glial cell line-derived neurotrophic factor using a lentiviral vector induces time- and dose-dependent downregulation of tyrosine hydroxylase in the intact nigrostriatal dopamine system. J. Neurosci. 24, 6437-6445.
16. GOSSEN, M., and BUJARD, H. (1992). Tight control of gene expression in mammalian cells by tetracycline responsive promoters. Proc. Natl. Acad. Sci. U.S.A. 89, 5547-5551.
17. KIRIK, D., ROSENBLAD, C., BJÖRKLUND, A., and MANDEL R.J. (2000). Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: Intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system. J. Neurosci. 20, 4686-4700.
18. KORDOWER, J.H., EMBORG, M.E., BLOCH, J., MA, S.Y., CHU, Y., LEVENTHAL, L., MCBRIDE, J., CHEN, E.Y., PALFI, S., ROITBERG, B.Z., BROWN, W.D., HOLDEN, J.E., PYZALSKI, R., TAYLOR, M.D., CARVEY, P., LING, Z., TRONO, D., HANTRAYE, P., DÉGLON, N., and AEBISCHER, P. (2000). Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290, 767-773.
19. LATTA-MAHIEU, M., ROLLAND, M., CAILLET, C., WANG, M., KENNEL, P., MAH-FOUZ, I., LOQUET, I., DEDIEU, J.-F., MAHFOUDI, A., TRANNOY, E., and THUILLIER, V. (2002). Gene transfer of a chimeric transactivator is immunogenic and results in short-lived transgene expression. Hum. Gene Ther. 13, 1611-1620.
20. MCGEE SANFTNER, L.H., ABEL, H., HAUSWIRTH, W.W., and FLANNERY, J.G. (2001). Glial cell line derived neurotrophic factor delays photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa. Mol. Ther. 4, 622-629.
21. MIYAZAKI, S., YAMATO, E., and MIYAZAKI, J.-I. (2004). Regulated expression of pdx-1 promotes in vitro differentiation of insulin-producing cells from embryonic stem cells. Diabetes 53, 1030-1037.
22. POLLOCK, R., ISSNER, R., ZOLLER, K., NATESAN, S., RIVERA, V.M., and CLACKSON, T. (2000). Delivery of a stringent dimerizer-regulated gene expression system in a single retroviral vector. Proc. Natl. Acad. Sci. U.S.A. 97, 13221-13226.
23. POLLOCK, R., GIEL, M., LINHER, K., and CLACKSON, T. (2002). Regulation of endogenous gene expression with a small-molecule dimerizer. Nat. Biotechnol. 20, 729-733.
24. RIVERA, V.M., CLACKSON, T., NATESAN, S., POLLOCK, R., AMARA, J.F., KEENAN, T., MAGARI, S.R., PHILLIPS, T., COURAGE, N.L., CERASOLI, F., HOLT, D.A., and GILMAN, M. (1996). A humanized system for pharmacologic control of gene expression. Nat. Med. 2, 1028-1032.
25. RIVERA, V.M., WANG, X., WARDWELL, S., COURAGE, N.L., VOLCHUK, A., KEENAN, T., HOLT, D.A., GILMAN, M., ORCI, L., CERASOLI, F., ROTHMAN, J.E., and CLACKSON, T. (2000). Regulation of protein secretion through controlled aggregation in the endoplasmic reticulum. Science 287, 826-830.
26. ROLLINS, C.T., RIVERA, V.M., WOOLFSON, D.N., KEENAN, T., HATADA, M., ADAMS, S.E., ANDRADE, L.J., YAEGER, D., VAN SCHRAVENDIJK, M.R., HOLT, D.A., GILMAN, M., and CLACKSON, T. (2000). A ligand-reversible dimerization system for controlling protein-protein interactions. Proc. Natl. Acad. Sci. U.S.A. 97, 7096-7101.
27. SAJADI, A., BAUER, M., THÖNY, B., and AEBISCHER, P. (2005). Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production. J. Neurochem. 93, 1482-1486.
28. SANFTNER, L.M., RIVERA, V.M., SUZUKI, B.M., FENG, L., BERK, L., ZHOU, S., FOR-SAYETH, J.R., CLACKSON, T., and CUNNINGHAM, J. (2006). Dimerizer regulation of AADC expression and behavioral response in AAV-transduced 6-OHDA lesioned rats. Mol. Ther. 13, 167-174.
29. STIEGER, K., LE MEUR, G., LASNE, F., WEBER, M., DESCHAMPS, J.Y., NIVARD, D., MENDES-MADEIRA, A., PROVOST, N., MARTIN, L., MOULLIER, P., and ROLLING, F. (2006). Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors. Mol. Ther. 13, 967-975.
30. URLINGER, S., BARON, U., THELLMANN, M., HASAN, M.T., BUJARD, H., and HILLEN, W. (2000). Exploring the sequence space for tetracycline-dependent transcriptional activators: Novel mutations yield expanded range and sensitivity. Proc. Natl. Acad. Sci. U.S.A. 97, 7963-7968.
31. VIGNA, E., CAVALIERI, S., AILLES, L., GEUNA, M., LOEW, R., BUJARD, H., and NALDINI, L. (2002). Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors. Mol. Ther. 5, 252-261.
32. VOGEL, R., AMAR, L., DO THI, A., SAILLOUR, P., and MALLET, J. (2004). A single lentivirus vector mediates doxycycline-regulated expression of transgenes in the brain. Hum. Gene Ther. 15, 157-165.
33. WANG, L.-J., LU, Y.Y., MURAMATSU, S., IKEGUCHI, K., FUJIMOTO, K., OKADA, T., MIZUKAMI, H., MATSUSHITA, T., HANAZONO, Y., KUME, A., NAGATSU, T., OZAWA, K., and NAKANO, I. (2002). Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis. J. Neurosci. 22, 6920-6928.
34. YANCOPOULOS, G.D., DAVIS, S., GALE, N.W., RUDGE, J.S., WIEGAND, S.J., and HOLASH, J. (2000). Vascular-specific growth factors and blood vessel formation. Nature 407, 242-248.
35. ZENNOU, V., SERGUERA, C., SARKIS, C., COLIN, P., PERRET, E., MALLET, J., and CHARNEAU, P. (2001). The HIV-1 DNA flap stimulates HIV vector mediated cell transduction in the brain. Nat. Biotechnol. 19, 446-450.
36. ZHU, Z., ZHENG, T., LEE, C.G., HOMER, R.J., and ELIAS, J.A. (2002). Tetracycline-controlled transcriptional regulation systems: Advances and application in transgenic animal modelling. Semin. Cell. Dev. Biol. 13, 121-128.
37. ZUFFEREY, R., NAGY, D., MANDEL, R.J., NALDINI, L., and TRONO, D. (1997). Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15, 871-875.
38. ZUFFEREY, R., DULL, T., MANDEL, R.J., BUKOVSKY, A., QUIROZ, D., NALDINI, L., and TRONO, D. (1998). Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72, 9873-9880.
39. ZUFFEREY, R., DONELLO, J.E., TRONO, D., and HOPE, T.J. (1999). Woodchuck hepatitis virus posttrancriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J. Virol. 73, 2886-2892.